Johnson & Johnson (JNJ) earnings Q4 2023


The stock trading graph of Johnson & Johnson is seen on a smartphone screen.

Rafael Henrique | SOPA Images | LightRocket | Getty Images

Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical and medical devices businesses surged.

J&J also provided full-year guidance for 2024, forecasting sales of $87.8 billion to $88.6 billion and adjusted earnings of $10.55 to $10.75 per share.

Here’s what J&J reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv:

  • Earnings per share: $2.29 adjusted vs….

Source cnbc.com

0 0 votes
Article Rating

Procter & Gamble (PG) Q2 2024 earnings

Previous article

SAP shares surge to all-time high after results, plans to restructure 8,000 jobs in push to AI

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings